Cargando…
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
Cardiovascular diseases are the leading cause of death worldwide. Research in the last two decades has emphasized the inflammatory process as a key component in the pathogenesis of many of them. The Interleukin-1 family is a pivotal element of inflammation and has been well studied as a therapeutic...
Autores principales: | Szekely, Yishay, Arbel, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986669/ https://www.ncbi.nlm.nih.gov/pubmed/29417406 http://dx.doi.org/10.1007/s40119-018-0104-3 |
Ejemplares similares
-
Precision diabetes: Where do we stand today?
por: Mohan, Viswanathan, et al.
Publicado: (2018) -
Oesophageal Adenocarcinomas: Where Do We Stand Today?
por: Karstens, Karl-Frederick, et al.
Publicado: (2020) -
The Ethics of Machine Learning in Medical Sciences: Where Do We Stand Today?
por: Basu, Treena, et al.
Publicado: (2020) -
Prenatal Screening for Chromosomal Abnormalities: Where do We Stand Today in Mediterranean Countries?
por: Rizos, Demetrios
Publicado: (2018) -
Antibiotic Prophylaxis for Children with Primary Vesicoureteral Reflux: Where Do We Stand Today?
por: Costers, Michiel, et al.
Publicado: (2008)